Western Blotting Market by Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies) - Global Forecasts to 2021

Publisher Name :
Date: 09-Nov-2016
No. of pages: 169
Inquire Before Buying

The western blotting market is projected to reach USD 730.7 million by 2021 from USD 574.8 million in 2016, at a CAGR of 4.9% in the next five years (2016 to 2021).

The western blotting market is undergoing a significant transformation, with the automation of blotting systems and imagers. Furthermore, it is one of the most basic technologies for the separation of proteins and is seen at almost every protein research laboratories. The growth of this market is majorly influenced by the dynamics of the protein research industries.

The increasing number of research activities and R&D spending by pharmaceutical and biotechnology companies, rising prevalence of HIV/AIDS, growing proteomics market, the growing number of industry-academic research collaborations, increasing demand for personalized medicine, and new product launches  are some factors expected to drive the growth of the global western blotting market in the coming years. On the other hand, emergence of alternative technologies is expected to restrain the growth of the market. However, automation in western blotting instruments is expected to pose lucrative opportunities for the western blotting market. Furthermore, stringent regulations and requirement of high procedural efficiency for accurate results are likely to challenge the western blotting market in the coming years.

In 2016, North America is expected to account for the largest share of the global western blotting market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW).North America’s large share is attributed to the increasing prevalence of HIV and Lyme disease, U.S. –China collaborative program for biomedical research, rise in research funding & increasing production of genetically modified crops in the U.S., HIV vaccine initiative, and Growing intensity of pharmaceutical and biopharmaceutical clinical research in Canada. In the coming years, the western blotting market is expected to witness the highest growth in the Asia-Pacific region, with emphasis on India, China, and Japan. This can be attributed to factors such as presence of bioclusters in China and India, outsourcing of research activity in China, increasing government interest in biomedical & biotechnology industry in China, government initiatives supported by funding in Japan, growing pharmaceutical & biotechnology industry in Japan, growing pharmaceutical industry backed by government funding in India, and growing funding for agriculture research in India.

The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (expansions; new product launches; marketing and promotion; agreements, collaborations, partnerships, and joint ventures; funding; acquisitions; and product enhancement to increase their market shares and establish a strong foothold in the global market.   

In-depth interviews were conducted with CEOs, Sales and Marketing Directors, other innovation and technology directors, and executives from various key organizations operating in the adaptive security market place.


  • By Company Type: Tier 1: 50%, Tier 2: 35%, Tier 3: 15%

  • By Designation: Director Level: 53%, C-Level: 28%, Others: 19%

  • By Region: North America: 35%, Europe: 25%, APAC: 28%, ROW: 12%


The report includes the study of key players offering western blotting such as Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), GE Healthcare (U.S.), Advasta, Inc. (U.S.), LI-COR Biosciences (U.S.), PerkinElmer, Inc. (U.S.), Bio-Techne Corporation (U.S.), Merck KGaA (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), and Cell Signaling Technology, Inc. (U.S.).

Research Coverage:

The report provides a picture on western blotting instruments and consumables across different applications and regions. It aims at estimating the market size and future growth potential of this market across different segments such as product, application, end user, and regions. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market by providing them the closest approximations of the revenue numbers for the overall western blotting market and the sub segments. This report will help stakeholders to better understand the competitor landscape and gain more insights to better position their businesses and make suitable go-to-market strategies. The report also helps the stakeholders to understand the pulse of the market and provides them information on key market drivers, restraints, challenges, and opportunities.

Western Blotting Market by Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies) - Global Forecasts to 2021

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.1.1 Key Data From Secondary Sources
2.2.2 Primary Research
2.2.2.1 Key Data From Primary Sources
2.2.2.2 Key Insights From Primary Sources
2.2.2.3 Key Industry Insights
2.3 Market Size Estimation Methodology
2.4 Market Data Validation and Triangulation
2.5 Assumptions for the Study

3 Executive Summary
3.1 Introduction
3.2 Conclusion

4 Premium Insights
4.1 Western Blotting: Market Overview
4.2 Geographic Analysis: Western Blotting Market, By End User
4.3 Market, By Product
4.4 Market, By Application
4.5 Market, By End User
4.6 Geographic Snapshot: Western Blotting Market

5 Market Overview
5.1 Introduction
5.1.1 Market Drivers
5.1.1.1 Increasing Research Activities and R&D Spending By Pharmaceutical and Biotechnology Companies
5.1.1.2 Rising Prevalence of HIV/Aids
5.1.1.3 Growing Proteomics Market
5.1.1.4 Growing Number of Industry-Academic Research Collaborations
5.1.1.5 Increasing Demand for Personalized Medicine
5.1.1.6 New Product Launches
5.1.2 Market Restraints
5.1.2.1 Emergence of Alternative Technologies
5.1.3 Market Opportunities
5.1.3.1 Automation in Western Blotting Instruments
5.1.3.2 Emerging Economies to Offer Significant Growth Opportunities for the Western Blotting Market
5.1.4 Market Challenges
5.1.4.1 Requirement of High Procedural Efficiency for Accurate Results
5.1.4.2 Stringent Regulations

6 Global Western Blotting Market, By Product
6.1 Introduction
6.2 Consumables
6.2.1 Reagents
6.2.2 Kits
6.2.3 Other Consumables
6.3 Instruments
6.3.1 Gel Electrophoresis Instruments
6.3.2 Blotting Systems
6.3.2.1 Wet Blotting Systems
6.3.2.2 Semi-Dry Blotting Systems
6.3.3 Imagers
6.3.3.1 Chemiluminescent Imagers
6.3.3.2 Fluorescent Imagers
6.3.3.3 Other Imagers

7 Western Blotting Market, By Application
7.1 Introduction
7.2 Biochemical & Biomedical Research
7.3 Disease Diagnostics
7.4 Agriculture
7.5 Other Applications

8 Western Blotting Market, By End User
8.1 Introduction
8.2 Academic and Research Institutes
8.3 Pharmaceutical and Biotechnology Companies
8.4 Diagnostic Laboratories
8.5 Other End Users

9 Western Blotting Market, By Region
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.1.1 Increasing Prevalence of HIV and Lyme Disease
9.2.1.2 U.S.-China Collaborative Program for Biomedical Research
9.2.1.3 Rise in Research Funding and Increasing Production of Genetically Modified Crops
9.2.1.4 Conferences, Meetings, and Symposiums
9.2.2 Canada
9.2.2.1 HIV Vaccine Initiative
9.2.2.2 Growing Intensity of Pharmaceutical and Biopharmaceutical Clinical Research
9.3 Europe
9.3.1 Europe-5
9.3.1.1 Strong Academic and Research Base in Germany
9.3.1.2 Availability of Research Funding in the U.K.
9.3.1.3 Growth in the Spanish Biotechnology Industry
9.3.2 RoE
9.3.2.1 High Presence of Pharmaceutical and Biotechnology Companies
9.3.2.2 Conferences, Workshops, and Congresses on Western Blotting Application Areas
9.4 Asia-Pacific
9.4.1 China
9.4.1.1 Increasing Government Interest in Biomedical and Biotechnology Industry
9.4.1.2 Presence of Bioclusters in China
9.4.1.3 Outsourcing of Clinical Research Activity to China
9.4.2 Japan
9.4.2.1 Government Initiatives Supported By Funding
9.4.2.2 Growing Pharmaceutical and Biotechnology Industry in Japan
9.4.3 India
9.4.3.1 Growing Pharmaceutical Industry in India, Backed By Government Initiatives
9.4.3.2 Development of Bioclusters
9.4.3.3 Growing Funding for Agriculture Research in India
9.4.4 RoAPAC
9.4.4.1 Korea-U.S. Free Trade Agreement (Korus)
9.4.4.2 Increasing Diagnosis of HIV and Related Funding in Australia
9.4.4.3 Growing Prevalence of Herpes Simplex Virus in Southeast Asia
9.5 RoW
9.5.1 Rising Prevalence of HIV in the Middle East and Africa
9.5.2 Increasing Focus of Pharmaceutical Companies on Africa
9.5.3 Presence of Large End-User Base in Brazil

10 Competitive Landscape
10.1 Overview
10.2 Market Share Analysis
10.2.1 Introduction
10.2.2 Bio-Rad Laboratories, Inc. (U.S.)
10.2.3 Thermo Fisher Scientific, Inc. (U.S.)
10.2.4 GE Healthcare (U.S.)
10.3 Competitive Situation and Trends
10.3.1 Product Launches
10.3.2 Acquisitions
10.3.3 Agreements, Partnerships, and Collaborations
10.3.4 Expansions
10.3.5 Others

11 Company Profiles
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 Introduction
11.2 Bio-Rad Laboratories, Inc.
11.3 Thermo Fisher Scientific, Inc.
11.4 GE Healthcare
11.5 Advansta Inc.
11.6 Li-Cor Biosciences
11.7 Perkinelmer, Inc.
11.8 Bio-Techne Corporation
11.9 F. Hoffmann-La Roche Ltd.
11.10 Merck Kgaa
11.11 Cell Signaling Technology

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix
12.1 Discussion Guide
12.2 Other Developments
12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.4 Introducing RT: Real-Time Market Intelligence
12.4.1 Features and Benefits of Rt:
12.5 Available Customization
12.5.1 Portfolio Analysis
12.5.2 Company Information
12.6 Related Reports
12.7 Author Details

List of Tables

Table 1 Number of New HIV Infections and AIDS Related Deaths in 2015
Table 2 Indicative List of New Product Launches By Key Players in the Western Blotting Market Between 2013 and 2016
Table 3 Market Size, By Product, 2014–2021 (USD Million)
Table 4 Western Blotting Consumables Market Size, By Type, 2014–2021 (USD Million)
Table 5 Western Blotting Consumables Market Size, By Region, 2014–2021 (USD Million)
Table 6 Western Blotting Reagents Market Size, By Region, 2014–2021 (USD Million)
Table 7 Western Blotting Kits Market Size, By Region, 2014–2021 (USD Million)
Table 8 Comparison of Nitrocellulose Membranes and Pvdf Membranes
Table 9 Western Blotting Other Consumables Market Size, By Region, 2014–2021 (USD Million)
Table 10 Western Blotting Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 11 Western Blotting Instruments Market Size, By Region, 2014–2021 (USD Million)
Table 12 Gel Electrophoresis Instruments Market Size, By Region, 2014–2021 (USD Million)
Table 13 Comparison of Protein Blotting Systems
Table 14 Blotting Systems Market Size, By Type, 2014–2021 (USD Million)
Table 15 Blotting Systems Market Size, By Region, 2014–2021 (USD Million)
Table 16 Wet Blotting Systems Market Size, By Region, 2014–2021 (USD Million)
Table 17 Semi-Dry Blotting Systems Market Size, By Region, 2014–2021 (USD Million)
Table 18 Imagers Market Size, By Type, 2014–2021 (USD Million)
Table 19 Imagers Market Size, By Region, 2014–2021 (USD Million)
Table 20 Chemiluminescent Imagers Market Size, By Region, 2014–2021 (USD Million)
Table 21 Fluorescent Imagers Market Size, By Region, 2014–2021 (USD Million)
Table 22 Other Imagers Market Size, By Region, 2014–2021 (USD Million)
Table 23 Market Size, By Application, 2014–2021 (USD Million)
Table 24 Market Size for Biomedical and Biochemical Research, By Region, 2014–2021 (USD Million)
Table 25 Market Size for Disease Diagnostics, By Region, 2014–2021 (USD Million)
Table 26 Market Size for Agriculture, By Region, 2014–2021 (USD Million)
Table 27 Market Size for Other Applications, By Region, 2014–2021 (USD Million)
Table 28 Market Size, By End User, 2014–2021 (USD Million)
Table 29 Academic & Research Institutes Market Size, By Region, 2014–2021 (USD Million)
Table 30 Pharmaceutical & Biotechnology Companies Market Size, By Region, 2014–2021 (USD Million)
Table 31 Hsv-1 Prevalence and New Cases Across Various Geographies in 2012 (Age 0-49)
Table 32 Diagnostic Centers Market Size, By Region, 2014–2021 (USD Million)
Table 33 Other End Users Market Size, By Region, 2014–2021 (USD Million)
Table 34 North America: Market Size, By Country, 2014–2021 (USD Million)
Table 35 North America: Market Size, By Product, 2014–2021 (USD Million)
Table 36 North America: Western Blotting Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 37 North America: Blotting Systems Market Size, By Type, 2014–2021 (USD Million)
Table 38 North America: Imagers Market Size, By Type, 2014–2021 (USD Million)
Table 39 North America: Consumables Market Size, By Type, 2014–2021 (USD Million)
Table 40 North America: Market Size, By Application, 2014–2021 (USD Million)
Table 41 North America: Market Size, By End User, 2014–2021 (USD Million)
Table 42 Grants Provided for the Development of Gm Crops, 2015
Table 43 Conferences in U.S. Between 2013 and 2017
Table 44 U.S.: Market Size, By Product, 2014–2021 (USD Million)
Table 45 U.S.: Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 46 U.S.: Blotting Systems Market Size, By Type, 2014–2021 (USD Million)
Table 47 U.S.: Imagers Market Size, By Type, 2014–2021 (USD Million)
Table 48 U.S.: Consumables Market Size, By Type, 2014–2021 (USD Million)
Table 49 U.S.: Market Size, By Application, 2014–2021 (USD Million)
Table 50 U.S.: Market Size, By End User, 2014–2021 (USD Million)
Table 51 Canada: Market Size, By Product, 2014–2021 (USD Million)
Table 52 Canada: Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 53 Canada: Blotting Systems Market Size, By Type, 2014–2021 (USD Million)
Table 54 Canada: Imagers Market Size, By Type, 2014–2021 (USD Million)
Table 55 Canada: Consumables Market Size, By Type, 2014–2021 (USD Million)
Table 56 Canada: Market Size, By Application, 2014–2021 (USD Million)
Table 57 Canada: Market Size, By End User, 2014–2021 (USD Million)
Table 58 Europe: Market Size, By Country, 2014–2021 (USD Million)
Table 59 Europe: Market Size, By Product, 2014–2021 (USD Million)
Table 60 Europe: Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 61 Europe: Blotting Systems Market Size, By Type, 2014–2021 (USD Million)
Table 62 Europe: Imagers Market Size, By Type, 2014–2021 (USD Million)
Table 63 Europe: Consumables Market Size, By Type, 2014–2021 (USD Million)
Table 64 Europe: Market Size, By Application, 2014–2021 (USD Million)
Table 65 Europe: Market Size, By End User, 2014–2021 (USD Million)
Table 66 Europe-5: Market Size, By Product, 2014–2021 (USD Million)
Table 67 Europe-5: Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 68 Europe-5: Blotting Systems Market Size, By Type, 2014–2021 (USD Million)
Table 69 Europe-5: Imagers Market Size, By Type, 2014–2021 (USD Million)
Table 70 Europe-5: Consumables Market Size, By Type, 2014–2021 (USD Million)
Table 71 Europe-5: Market Size, By Application, 2014–2021 (USD Million)
Table 72 Europe-5: Market Size, By End User, 2014–2021 (USD Million)
Table 73 Indicative List: Companies Headquartered in RoE Countries
Table 74 Indicative List: Conferences, Symposia, & Workshops in Europe (2015 and 2016)
Table 75 RoE: Market Size, By Product, 2014–2021 (USD Million)
Table 76 RoE: Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 77 RoE: Blotting Systems Market Size, By Type, 2014–2021 (USD Million)
Table 78 RoE: Imagers Market Size, By Type, 2014–2021 (USD Million)
Table 79 RoE: Consumables Market Size, By Type, 2014–2021 (USD Million)
Table 80 RoE: Western Blotting Market Size, By Application, 2014–2021 (USD Million)
Table 81 RoE: Western Blotting Market Size, By End User, 2014–2021 (USD Million)
Table 82 Asia-Pacific: Western Blotting Market Size, By Country, 2014–2021 (USD Million)
Table 83 Asia-Pacific: Western Blotting Market Size, By Product, 2014–2021 (USD Million)
Table 84 Asia-Pacific: Western Blotting Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 85 Asia-Pacific: Blotting Systems Market Size, By Type, 2014–2021 (USD Million)
Table 86 Asia-Pacific: Imagers Market Size, By Type, 2014–2021 (USD Million)
Table 87 Asia-Pacific: Western Blotting Consumables Market Size, By Type, 2014–2021 (USD Million)
Table 88 Asia-Pacific: Western Blotting Market Size, By Application, 2014–2021 (USD Million)
Table 89 Asia-Pacific: Western Blotting Market Size, By End User, 2014–2021 (USD Million)
Table 90 China: Western Blotting Market Size, By Product, 2014–2021 (USD Million)
Table 91 China: Western Blotting Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 92 China: Blotting Systems Market Size, By Type, 2014–2021 (USD Million)
Table 93 China: Imagers Market Size, By Type, 2014–2021 (USD Million)
Table 94 China: Western Blotting Consumables Market Size, By Type, 2014–2021 (USD Million)
Table 95 China: Western Blotting Market Size, By Application, 2014–2021 (USD Million)
Table 96 China: Western Blotting Market Size, By End User, 2014–2021 (USD Million)
Table 97 Amed Funding Priorities for Research in 2015
Table 98 Japan: Western Blotting Market Size, By Product, 2014–2021 (USD Million)
Table 99 Japan: Western Blotting Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 100 Japan: Blotting Systems Market Size, By Type, 2014–2021 (USD Million)
Table 101 Japan: Imagers Market Size, By Type, 2014–2021 (USD Million)
Table 102 Japan: Western Blotting Consumables Market Size, By Type, 2014–2021 (USD Million)
Table 103 Japan: Western Blotting Market Size, By Application, 2014–2021 (USD Million)
Table 104 Japan: Western Blotting Market Size, By End User, 2014–2021 (USD Million)
Table 105 Research Programs Funded in Fy 2015-2016
Table 106 India: Western Blotting Market Size, By Product, 2014–2021 (USD Million)
Table 107 India: Western Blotting Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 108 India: Blotting Systems Market Size, By Type, 2014–2021 (USD Million)
Table 109 India: Imagers Market Size, By Type, 2014–2021 (USD Million)
Table 110 India: Western Blotting Consumables Market Size, By Type, 2014–2021 (USD Million)
Table 111 India: Western Blotting Market Size, By Application, 2014–2021 (USD Million)
Table 112 India: Western Blotting Market Size, By End User, 2014–2021 (USD Million)
Table 113 RoAPAC: Western Blotting Market Size, By Product, 2014–2021 (USD Million)
Table 114 RoAPAC: Western Blotting Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 115 RoAPAC: Blotting Systems Market Size, By Type, 2014–2021 (USD Million)
Table 116 RoAPAC: Imagers Market Size, By Type, 2014–2021 (USD Million)
Table 117 RoAPAC: Western Blotting Consumables Market Size, By Type, 2014–2021 (USD Million)
Table 118 RoAPAC: Western Blotting Market Size, By Application, 2014–2021 (USD Million)
Table 119 RoAPAC: Western Blotting Market Size, By End User, 2014–2021 (USD Million)
Table 120 HIV Infections and AIDS-Related Deaths in the Middle East and Africa, 2015
Table 121 RoW: Western Blotting Market Size, By Product, 2014–2021 (USD Million)
Table 122 RoW: Western Blotting Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 123 RoW: Blotting Systems Market Size, By Type, 2014–2021 (USD Million)
Table 124 RoW: Imagers Market Size, By Type, 2014–2021 (USD Million)
Table 125 RoW: Western Blotting Consumables Market Size, By Type, 2014–2021 (USD Million)
Table 126 RoW: Western Blotting Market Size, By Application, 2014–2021 (USD Million)
Table 127 RoW: Western Blotting Market Size, By End User, 2014–2021 (USD Million)
Table 128 Product Launches, 2013–2016
Table 129 Acquisitions, 2013–2016
Table 130 Agreements, Partnerships, and Collaborations, 2013–2016
Table 131 Expansions, 2013–2016
Table 132 Others, 2013–2016

List of Figures

Figure 1 Western Blotting Market Segmentation
Figure 2 Research Methodology: Western Blotting Market
Figure 3 Sampling Frame: Primary Research
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Western Blotting Market Size Estimation Methodology: Bottom-Up Approach
Figure 6 Western Blotting Market Size Estimation Methodology: Top-Down Approach
Figure 7 Research Design
Figure 8 Data Triangulation Methodology
Figure 9 The Consumables Product Segment to Command the Larger Share of the Western Blotting Market in 2016
Figure 10 The Biomedical and Biochemical Application Segment to Command the Largest Market Share in 2016
Figure 11 Academic & Research Institutes to Dominate the Western Blotting End-User Market During the Forecast Period
Figure 12 Asia-Pacific to Witness the Highest Market Growth During the Forecast Period
Figure 13 Asia-Pacific Offers Significant Growth Opportunities for the Western Blotting Market
Figure 14 Academic & Research Institutes to Dominate the Western Blotting Market
Figure 15 Consumables Segment to Register the Highest Growth During the Forecast Period
Figure 16 Biomedical & Biochemical Research to Dominate the Global Western Blotting Market in 2016
Figure 17 Academic & Research Institutes Segment Will Command the Largest Share of the Market in 2016
Figure 18 Asia-Pacific to Register Highest Growth Rate From 2016 to 2021
Figure 19 Western Blotting Market: Drivers, Restraints, Opportunities, and Challenges
Figure 20 Consumables Segment to Dominate the Market in 2016
Figure 21 Western Blotting Market Segmentation
Figure 22 Biomedical and Biochemical Research to Dominate the Market in 2016
Figure 23 Academic & Research Institutes to Dominate the Market in 2016
Figure 24 North America to Command the Largest Share of the Western Blotting Market in 2016
Figure 25 North America: Western Blotting Market Snapshot
Figure 26 Biopharmaceutical Pipeline, By Stage of Development (In March 2014)
Figure 27 Canada: Clinical Trials Conducted (January 2013 to September 2016)
Figure 28 Europe: Western Blotting Market Snapshot
Figure 29 Asia-Pacific: Western Blotting Market Snapshot
Figure 30 RoW: Western Blotting Market Snapshot
Figure 31 Market Share Analysis, By Key Player, 2015
Figure 32 Key Developments Pursued By Prominent Players in the Western Blotting Market, 2013–2016
Figure 33 Product Launch—Key Growth Strategy Adopted By Players 2013-2016
Figure 34 Geographic Revenue Mix of the Prominent Players in the Western Blotting Market
Figure 35 Bio-Rad Laboratories, Inc.: Company Snapshot
Figure 36 Thermo Fisher Scientific, Inc.: Company Snapshot
Figure 37 GE Healthcare: Company Snapshot
Figure 38 Perkinelmer, Inc.: Company Snapshot
Figure 39 Bio-Techne Corporation: Company Snapshot
Figure 40 F. Hoffmann-La Roche Ltd.: Company Snapshot
Figure 41 Merck Kgaa: Company Snapshot

  • United States G-Protein Coupled Receptor Market Report 2016
    Published: 02-Dec-2016        Price: US 3800 Onwards        Pages: 105
    Notes: Sales, means the sales volume of G-Protein Coupled Receptor Revenue, means the sales value of G-Protein Coupled Receptor This report studies sales (consumption) of G-Protein Coupled Receptor in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Anchor Therapeutics (USA) - Arena Pharmaceuticals, Inc. (US) - 7TM Pharma A/S (Denmark) - Acadia Pharmaceuticals Inc., (......
  • United States G-Protein Coupled Receptor (GPCR) Targeting Market Report 2016
    Published: 01-Dec-2016        Price: US 3800 Onwards        Pages: 108
    Notes: Sales, means the sales volume of G-Protein Coupled Receptor (GPCR) Targeting Revenue, means the sales value of G-Protein Coupled Receptor (GPCR) Targeting This report studies sales (consumption) of G-Protein Coupled Receptor (GPCR) Targeting in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - ABBVIE - ABBOTT LABORATORIES - ACTELION PHARMACEUTICALS - ADDEX THERA......
  • United States Proteomics Market Report 2016
    Published: 29-Nov-2016        Price: US 3800 Onwards        Pages: 104
    Notes: Sales, means the sales volume of Proteomics Revenue, means the sales value of Proteomics This report studies sales (consumption) of Proteomics in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - AB Sciex (Danaher) - Agilent Technologies - Bruker Corporation - Thermo Fisher Scientific - Waters Corporation - Bio-Rad Laboratories - GE Healthca......
  • Heat Shock Protein (Hsp) Inhibitors -Pipeline Insights, 2016
    Published: 01-Nov-2016        Price: US 1250 Onwards        Pages: 60
    DelveInsight's, "Heat Shock Protein (Hsp) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Heat Shock Protein (Hsp) Inhibitors. The DelveInsight's Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology......
  • Heat Shock Protein 27 (Hsp27) Inhibitors -Pipeline Insights, 2016
    Published: 01-Nov-2016        Price: US 1250 Onwards        Pages: 60
    DelveInsight's, "Heat Shock Protein 27 (Hsp27) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Heat Shock Protein 27 (Hsp27) Inhibitors. The DelveInsight's Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including ......
  • Heat Shock Protein 70 (Hsp70) Inhibitors -Pipeline Insights, 2016
    Published: 01-Nov-2016        Price: US 1250 Onwards        Pages: 60
    DelveInsight's, "Heat Shock Protein 70 (Hsp70) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Heat Shock Protein 70 (Hsp70) Inhibitors. The DelveInsight's Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including ......
  • C1 Esterase Inhibitors -Pipeline Insights, 2016
    Published: 01-Nov-2016        Price: US 1250 Onwards        Pages: 60
    DelveInsight's, "C1 Esterase Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the C1 Esterase Inhibitors. The DelveInsight's Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaboration......
  • Calcium Sensing Receptor (CaR or CaSR) Antagonists -Pipeline Insights, 2016
    Published: 01-Nov-2016        Price: US 1250 Onwards        Pages: 60
    DelveInsight's, "Calcium Sensing Receptor (CaR or CaSR) Antagonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Calcium Sensing Receptor (CaR or CaSR) Antagonists. The DelveInsight's Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development a......
  • Cannabinoid Agonists -Pipeline Insights, 2016
    Published: 01-Nov-2016        Price: US 1250 Onwards        Pages: 60
    DelveInsight's, "Cannabinoid Agonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Cannabinoid Agonists. The DelveInsight's Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs